| Literature DB >> 35677200 |
Belay Tessema1,2,3, Ulrich Sack1, Brigitte König2, Zoya Serebrovska4, Egor Egorov5.
Abstract
Several studies have assessed the effects of intermittent hypoxia-normoxia training (IHNT), intermittent hypoxia-hyperoxia training (IHHT), and obstructive sleep apnea (OSA) on aging and age-related diseases in humans; however, the results remain contradictory. Therefore, this review aims to systematically summarize the available studies on the effects of IHNT, IHHT, and OSA on aging and age-related diseases. Relevant studies were searched from PubMed, Google Scholar, Cochrane Library databases, and through manual searching from reference lists of eligible studies. A total of 38 eligible studies were included in this systematic review. IHHT and IHNT provide positive effects on several age-related parameters including quality of life, cognitive and physical functions, plasma level of glucose and cholesterol/LDL, systolic blood pressure, red blood cells, and inflammation. Moreover, moderate intermittent hypoxia induces telomerase reverse transcriptase (TERT) activity and telomere stabilization, delays induction of senescence-associated markers expression and senescence-associated β-galactosidase, upregulates pluripotent marker (Oct4), activates a metabolic shift, and raises resistance to pro-apoptotic stimuli. On the contrary, intermittent hypoxia in OSA causes hypertension, metabolic syndrome, vascular function impairment, quality of life and cognitive scores reduction, advanced brain aging, increase in insulin resistance, plasma hydrogen peroxide, GSH, IL-6, hsCRP, leptin, and leukocyte telomere shortening. Thus, it can be speculated that the main factor that determines the direction of the intermittent hypoxia action is the intensity and duration of exposure. There is no direct study to prove that IHNT/IHHT actually increases life expectancy in humans. Therefore, further study is needed to investigate the actual effect of IHNT/IHHT on aging in humans. Systematic Review Registration: www.crd.york.ac.uk/prospero, identifier CRD42022298499.Entities:
Keywords: IHHT; IHNT; OSA; age-related diseases; aging biomarkers
Year: 2022 PMID: 35677200 PMCID: PMC9168371 DOI: 10.3389/fnagi.2022.878278
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
FIGURE 1PRISMA flow diagram shows the searching strategy and screening of eligible studies at different levels of the review process (Moher et al., 2009).
The effects of intermittent hypoxia-normoxia training (IHNT) on aging markers and age-related diseases.
| Author, year (ref.) | Condition | Age in years | Study design | Type of hypoxia | Hypoxia protocol | Aging markers | Results | Conclusion | Safety issues |
|
| Dizziness | 35–62 | RCT | IHNT | 10% O2 for 50 min, 5 times per week for 4 weeks. Each session has 5 cycles of 10% O2 for 5 min/room air for 5 min. | Dizziness | There were significant differences between IHNT group and control group in DHI, ABC, VVAS scores and attack frequencies of dizziness in the end of 4th week. | IHNT could improve dizziness after intervention in the end of 4th week. IHNT could be the effective method for releasing dizziness. | Safe |
|
| Overweight and obese | Mean, 56.2 | RCT | IHNT | 10% O2 repeated cycles with normoxia for 70 min, 10 sessions, 5 days/week for 2 weeks | Blood glucose and lactate | Glucose decreased and Lactate increased following a single IHNT session, but no sustained change after 10 sessions of IHNT occurred | IHNT appears to be a safe and effective non-pharmacological method of reducing key cardiovascular risk factors associated with metabolic disorders. | Safe |
| HDL and LDL | LDL, LDL/HDL were all significantly decreased after 10 sessions. | ||||||||
| SBP and DBP | SBP was significantly decreased after 10 sessions. No significant effects on DBP | ||||||||
| RMSSD and DFAα1 | No significant effects on heart rate, RMSSD, and DFAα1 | ||||||||
|
| COPD | mean, 50 (IHHT), 55 (control) | RCT | IHNT | 12–15% Fi O2 for 3 weeks. 5 sessions/week, each consisting of 3–5 cycles, each cycle 3–5 min with 3-min breaks between cycles. | SBP and DBP, heart rate | During IHNT, no between-group differences were detected for blood pressure or rate pressure product values. Changes in heart rate were significantly different between groups in the course of the 3 weeks, with | IHNT resulted in specific and moderate heart rate and blood pressure responses, and did not provoke a progressive increase in blood pressure. | Safe |
|
| Hypertensive patients | Mean range, 47–51 | RCT | IHNT | Eight events of FI O2 14%, and FI O2 21% for 6 weeks. Each cycle consisted of 8 cycles × 3-min hypoxic air alternating with 3 min normoxic air. | Blood pressure | a significant decrease of the SBP in both IHNT at rest (IHR) and during excessive (IHT) groups at days 2 and 28 post-intervention, respectively. | IHNT may act as an alternative therapeutic strategy for hypertension patients probably through elevation of NOx and HIF-1α production. | Not mentioned |
| Plasma NOx | IHR and IHT had increased NOx. At 2 days post-intervention, NOx was negatively correlated with SBP in IHT. | ||||||||
| HIF-1α | IHR and IHT had increased HIF-1α. At 2 days post-intervention, HIF-1α was negatively correlated with SBP in IHT. | ||||||||
| MDA levels | After 6 weeks of IHNT, MDA decreased to similar levels in the IHR and IHT compared to the control. | ||||||||
| The time to complete a 6-min walk. | Improved walk distance was maintained at day 28 post-intervention, compared to the control, for both the IHR and IHT. | ||||||||
|
| Healthy | 60–70 | RCT | IHNT | Three sessions/week, 1 session for 1 h, hypoxic for 10 min and normoxia for 5 min. In the first 2 weeks, 90% SpO2. In the 3rd week, 85% SpO2. and 80% SpO2 for the next 3 weeks. | Cognitive performance | A time × group effect was observed by d2 test. No interaction effect was discovered by ZVT. | IHNT combined with physical exercise augments the positive effects of exercise on cognitive performance and QoL in elderly humans. | Not mentioned |
| Quality of life (QoL) | An interaction effect was not found in the SF-12. But, an interaction effect was observed for sleep quality by PSQI. | ||||||||
|
| Healthy | 60–65 | RCT | IHNT | Hypoxia for 90 min followed by an aerobic training on bicycle ergometers for 30 min under ambient air. 3 times/week for 4 weeks. In the first week, the SpO2 between 90 and 85% and from the second to the fourth week 80%. | Physical performance | Increases the time to exhaustion | IHNT seems to be beneficial to enhance hematological parameters, physical performance and cognitive function in older people. The current hypoxic-dose was not able to enhance the serum BDNF-level or⋅VO2 max. | Not mentioned |
| Cognitive function | An augmented and sustainable improvement in cognitive function | ||||||||
| Hematological parameters (RBC, Hgb, Hct) | Increases in the values of hematological parameters | ||||||||
| Serum BDNF-level. | In both groups, the⋅VO2 max and serum BDNF-level did not increase. | ||||||||
|
| Healthy | Mean, 67 | Uncontrolled CT | IHNT and CHT | Three phases of training for 3 weeks: 2 weeks normal air and normoxia, 5 days IHT hypoxia (SpO2 of 85%) for 70 min. After a 5-month washout period, CHT (SpO2 = 85%, for 70 min). | RBC, Hgb Hct | RBC, and Hgb only increased by day 5 of IH treatment compared to day 5 baseline values and day 5 sham values. Hct did not change in either Sham-IH or Sham-CH regardless of the baseline values. | These results revealed that inherent differences in the IH and CH hypoxic patterns could provide crucial components required to trigger hematological changes in senior individuals, without eliciting immunological stress responses or damaging the myocardium. | Safe |
| Percentage of reticulocytes (% Retics), | % Retics did not change in either Sham-IH or Sham-CH regardless of the baseline values. | ||||||||
| The OFF-score | OFF-score value increased only during the final day of IH treatment. | ||||||||
| S-IgA, cortisol, cTnT | No difference was observed in S-IgA, cortisol or cTnT following IH or CH. | ||||||||
|
| Healthy | 18–35 (young) and 60–75 (old) | RCT | IHNT | The intensity of hypoxia was adjusted for 3 h with two approaches: (1) FiO2 13.5% (H-ext), and (2) the FiO2 (H-int) was individually adjusted to an SaO2 of the blood of 80%. | EPO | EPO increased significantly after 180 min in both cohorts (young and old) and in both investigations (H-ext and H-int). | After 180 min hypoxia, EPO increases significantly in both age cohorts. The amount of EPO expression is significantly higher in young people during the same internal intensity of hypoxia than in old people. | Safe |
|
| Lung cancer | Mean 62 (HPC), 63 (control) | RCT | IHNT | FiO2 was initially set at 60%, and in cases of saturation of pulse oxygenation (SpO2) less than 92%, FiO2 was increased to 100%. Three cycles of 5-min hypoxia and 3-min ventilation applied to the non-dependent lung served as the HPC intervention. | PaO2/FiO2 ratio, and pulmonary function. | HPC significantly increased the PaO2/FiO2 ratio compared with the control at 30 min after one-lung ventilation and 7 days after operation. Compared with the control, it also significantly improved postoperative pulmonary function. | HPC improves postoperative oxygenation, enhances the recovery of pulmonary function, and reduces the duration of hospital stay in patients undergoing thoracoscopic lobectomy. | |
| Postoperative pulmonary complications. | No significant differences between groups were observed in the incidence of pulmonary complications or overall postoperative morbidity. | ||||||||
| Duration of hospital stay. | Markedly reduced the postoperative hospital stay duration. |
IHNT, intermittent hypoxia-normoxia training; IHT, intermittent hypoxia training; RCT, randomized controlled clinical trial; DHI, the Dizziness Handicap Inventory; ABC, Activities-specific Balance Confidence Scale; VVAS, Vertigo Visual Analog Scale; HDL, high-density lipoprotein; LDL, low-density lipoproteins; SBP, systolic blood pressure; DBP, diastolic blood pressure; RMSSD, root mean square of successive R–R interval differences; DFAα1, short-term fractal scaling exponent; COPD, chronic obstructive pulmonary diseases; SaO
The effects of intermittent hypoxia-hyperoxia training (IHHT) on aging markers and age-related diseases.
| Author, year (ref.) | Condition | Age in years | Study design | Type of hypoxia | Hypoxia protocol | Aging markers | Results | Conclusion | Safety issues |
|
| Cardiac patients with comorbidities | Mean 66 (IHHT), 65 (control) | RCT | IHHT | 15 sessions hypoxia (11–12% O2)—hyperoxia (30–33% O2) for 5 weeks: 3 sessions/week, 5–7 hypoxic periods of 4–6 min, 3 min hyperoxic recovery. | CRF | CRF in the IHHT group was not significantly different compared with the control group. Systolic and diastolic blood pressures were not significantly different between groups after treatment. | IHHT might be a suitable option for older patients who cannot exercise. A 5-week IHHT is as effective as an 8-week exercise program in improving CRF, without hematological changes. | Safe |
| Hgb, RBC, reticulocyte | Hgb content was not significantly different between groups. RBC and reticulocytes did not change pre/post interventions in both experimental groups. | ||||||||
|
| coronary artery disease (CAD) | 43–83 | Non-RCT | IHHT | 15 sessions hypoxia (10% O2)- hyperoxia (30% O2). 3 sessions/week, 5–7 hypoxic periods lasting 4–6 min, with 3-min hyperoxic recovery. | Exercise performance | The IHHT showed improved exercise capacity, reduced systolic and diastolic blood pressures, enhanced left ventricle ejection fraction, but only at 1-month | IHHT is associated with improved exercise tolerance, healthier risks factors profile, and a better quality of life. The study also suggests that IHHT is as effective as an 8-week standard rehabilitation program in CAD patients. | Safe |
| Blood markers (RBC, Hgb, reticulocyte); metabolic profiles (total cholesterol, LDL and HDL, triglycerides, and glucose) | Hgb and glycemia were unchanged after IHHT, but glycemia was significantly lower at the 1-month follow-up. Total cholesterol and LDL were lower after IHHT. At the 1-month follow-up total cholesterol was similar to pretreatment. Reticulocytes were significantly higher in the IHHT at the end of treatment and at 1-month follow-up. | ||||||||
| Quality of life | The SAQ profile was improved and not significantly different to the control after standard rehabilitation. | ||||||||
|
| Prediabetic patients | 51–74 | RCT | IHHT and IHNT | 15 sessions IHHT and IHNT, 5 times/week for 3 weeks. Each session consisted of 4 cycles of 5 min of 12% FiO2 followed by 3 min of 33% O2 in nitrogen or 5 min of normoxia. | Serum total cholesterol, HDL, LDL, and triglycerides | The study showed the same positive effect of IHNT and IHHT: decreased total blood cholesterol and LDL; and an equally smaller drop in SpO2 during acute hypoxic test. Improved parameters persisted 1 month after training termination in both groups. | One of the advantages of IHHT over IHT observed in this study could be some reduction in the duration of the sessions due to shortening re-oxygenation periods. | Not mentioned |
| Plasma glucose concentrations | The study showed the same positive effect of IHHT and IHNT: equal reduction of serum glucose concentrations, both fasting and 2 h of OGTT. Improved parameters persisted 1 month after training termination in both groups. | ||||||||
|
| Healthy | 18–24 | Uncontrolled CT | IHHT and IHNT | FIO2 11% for up to 7 min followed by 3–5 min of exposure to normoxia (room air) or hyperoxia, FIO2 30–35% | Oxidative stress (concentration of hydroperoxides) | Oxidative stress was similar after IHN and IHH exposures compared with baseline values. | Hypoxia (IHN and IHH) cause neither pronounced oxidative stress nor antioxidant capacity impairment in healthy humans. | Safe |
| Antioxidant capacity | The antioxidant capacity was also similar between experimental groups after both modalities of exposure. |
IHHT, intermittent hypoxia-hyperoxia; IHNT, intermittent hypoxia-normoxia training; RCT, randomized controlled clinical trial; CRF, cardiorespiratory fitness; RBC, red blood cells; Hgb, hemoglobin; Hct, hematocrit; SAQ, Seattle Angina Questionnaire.
The effects of IHNT and CHT on aging markers and age-related diseases using cell culture.
| Author, year (ref.) | Targeted conditions | Cell line | Study design | Type of hypoxia | Hypoxia protocol (for cases) | Aging markers | Results | Conclusion | Safety issues |
|
| Cellular aging | hAFSCs | Non-RCT | CHT | 1% O2 for 5 weeks up to 8–9 passages. | Stemness properties (mRNA levels of Oct4 upregulation and protein expression of SSEA4) | 1% O2 extends stemness | Low oxygen concentrations might improve the generation of functional hAFSCs for therapeutic use by delaying the onset of cellular aging. | Not reported |
| Proliferative ability | 1% O2 extends proliferative features | ||||||||
| Induction of senescence-associated markers | 1% O2 delays induction of senescence-associated markers. | ||||||||
| Changes in metabolism and resistance to stress | Hypoxic hAFSCs activate a metabolic shift and increase resistance to pro-apoptotic stimuli. | ||||||||
| Osteogenic differentiation | Cells at low oxygen remain capable of osteogenesis for prolonged periods of time | ||||||||
|
| Skin aging | HDF | Non-RCT | CHT | 5% O2. HDF were passaged at 80% confluence. Cells were serially cultured until enough cells were obtained for all experiments. | Cellular proliferation rate | Increased cell proliferation under 21% O2 compared to 5% O2 | The 21% O2 impose a mild oxidative stress on HDF which accelerates the aging process in culture compared to 5% O2 where the underlying level of oxidative stress is reduced. cells grown under normoxia undergo a “stress-induced premature senescence” when compared to their matched counterparts grown under hypoxia. | Not reported |
| Intracellular ROS | Lower levels of intracellular ROS in cells at 21% O2 compared to those at 5% O2. | ||||||||
| Mitochondrial superoxide anion generation | Higher levels of mitochondrial superoxide anion in cells at 21% O2 compared to at 5% O2 | ||||||||
| CoQ10 level and oxidative status | Total coenzyme Q10 levels decrease with cell passages and increase with oxygen tension. | ||||||||
| Total glutathione | Total glutathione levels reduce under Low oxygen tension | ||||||||
| Single and double-strand DNA damage | DNA damage increased under 21% O2 vs. 5% O2. | ||||||||
| β-galactosidase activity, p16, CAT, SOD1, SOD3, MMP1, and COL1A1 genes expression | Higher levels of SOD1 and SOD3, upregulation of MMP1 and downregulation of COL1A1 under 21% O2 vs. 5% O2. | ||||||||
|
| Vascular disorder | VSMC | Non-RCT | CHT | 1% O2 until 10 passages. | Telomerase activity | Chronic hypoxia can prolong the growth of human VSMC by inducing telomerase activity and telomere stabilization. Hypoxia induced phosphorylation of the telomerase catalytic component (TERT) and sustained high levels of TERT protein expression in VSMC compared to normoxia. | Hypoxic induction of telomerase activity could be involved in long-term growth of VSMC and may thus contribute to human vascular disorders. | Not reported |
|
| Ischemic stroke | Mice microglia, EOC20 cells | Non-RCT | IHNT | Three days IHT consisting of 5–8 daily, 5–10 min cycles of hypoxia (3.5–4% O2) with intervening 4-min re-oxygenation. | Cell viability | Intermittent hypoxic training protects the microglia from oxygen–glucose deprivation/re-oxygenation stress. | Due to the effect of intermittent hypoxic training on the microglia phenotype, intermittent hypoxic training could be considered as an effective intervention in the treatment or rehabilitation program for the ischemic stroke victims. | Not reported |
| TLR2 proteins content | The TLR2 protein content was significantly elevated in the oxygen–glucose deprivation and re-oxygenation group, and intermittent hypoxic training lowered it to normoxia level. | ||||||||
| Anti-inflammatory cytokines (IL-10 and IL-4) | IL-10 and IL-4 were significantly increased in the intermittent hypoxic training groups. | ||||||||
| Reactive oxygen species (ROS) | Intermittent hypoxic training lowers the ROS generation | ||||||||
| Phagocytic activity | Intermittent hypoxic training increases phagocytic activity (about 12-fold) vs. normoxia. | ||||||||
| Cell phenotype | Intermittent hypoxic training regulates the polarization of the microglial phenotype toward anti-inflammatory type M2. | ||||||||
|
| OSA | HWPs | Non-RCT | IHNT | 9 cycles of IH (30 min of 21% O2 followed by 30 min of 0.1% O2) per day for up to 7 days | Senescence in HWPs | A higher prevalence of cells positive for senescence-associated β-galactosidase activity was also evident with chronic IH exposure. | This study identifies chronic IH as a trigger of senescence-like phenotype in preadipocytes. | Not reported |
hAFSCs, human amniotic fluid stem cells; CHT, continuous hypoxia training; IHT, intermittent hypoxia training; IH, intermittent hypoxia; non-RCT, non-randomized controlled trial; HDF, human dermal fibroblasts; VSMC, vascular smooth muscle cell; HPLC, high performance liquid chromatography; qPCR, quantitative polymerase chain reaction; ELISA, enzyme linked immunosorbent assay; OSA, obstructive sleep apnea; HWPs, human white preadipocytes; ROS, reactive oxygen species; TLR2, toll-like receptor 2.
The effects of sleep apnea on aging markers and age-related diseases.
| Author, year (ref.) | Condition | Age in years | Study design | Total quality score | Type of sleep apnea | Sleep apnea criteria | Aging markers | Results | Conclusion |
|
| SA | 47–93 | Case-control | OSA | High risk of OSA based on the Berlin Sleep Questionnaire. | Cognitive function | Those at high risk for OSA had significantly lower cognitive scores. However, some of the associations were age-dependent. Differences in cognition between those at high and low OSA risk were most pronounced during middle age, with attenuated effects after age 70 years. | Authors able to confirm OSA’s effect on cognition, depressive symptoms and HRQoL. They also found differential effects based on age, with more detrimental correlates of OSA in younger versus older adults, particularly in terms of mood and HRQoL. | |
| 8 | Depression | Those at high risk for OSA had significantly higher depressive symptoms. | |||||||
| HRQoL | Those at high risk for OSA had significantly lower HRQoL. However, some of the associations were age-dependent. Differences in quality of life between those at high and low OSA risk were most pronounced during middle age, with attenuated effects after age 70 years. | ||||||||
|
| SA | 25–59 | Case-control | 6 | OSA | AHI | Cognitive performance and brain activation | Middle-aged patients with OSA showed reduced performance for immediate word recall and slower reaction time during sustained attention. For both tasks, decreased activation was detected for middle-aged sleep apnea relative to the other groups in task-related brain regions. | The presence of both sleep apnea and increasing age overwhelmed the brain’s capacity to respond to cognitive challenges with compensatory recruitment and to maintain performance. |
|
| SA, and at risk for dementia | Mean, 65 | Cross-sectional | 7 | OSA | SA was determined based on O2-desaturation and AHI, rapid eye movement sleep, and non-rapid eye movement sleep. | GSH and creatine | Increased levels of GSH/Cr were associated with lower oxygen desaturation and more severe apnea-hypopnea index scores during rapid eye movement sleep. In addition, ACC GSH/Cr correlated with poorer executive functioning (i.e., response inhibition and set shifting). | Markers of nocturnal hypoxemia and sleep disordered breathing (SDB) are associated with cerebral oxidative stress in older people at-risk for dementia, suggesting a potential mechanism by which SDB may contribute to brain degeneration, cognitive decline, and dementia. |
|
| SA | 20-40 (young) and | Case-control | 7 | OSA | OSA patients with AHI > 10 events/h and were treated with CPAP for more than 5 h per night for at least 2 months prior to enrollment. | Pharyngeal anatomy/collapsibility | In comparison with younger patients with OSA, older patients had a more collapsible airway. | The data suggest that airway anatomy/collapsibility plays a relatively greater pathogenic role in older adults, whereas a sensitive ventilator control system is a more prominent trait in younger adults with OSA. |
| Loop gain (LG) | In comparison with younger patients with OSA, older patients had a lower LG | ||||||||
| UAG | It was similar between groups. | ||||||||
| RAT | It was similar between groups. | ||||||||
|
| SA | >65 | Cohort | 9 | OSA | OSA was diagnosed when AHI was >5 events/h. | Hct and Hgb | Hct changed significantly post OSA treatment. The change in Hgb after OSA treatment was not significant. However, the change in Hgb was large enough to reach WHO standards for AoA. Hct changed significantly among both men and women. | There was no AOA before OSA treatment. But there was AOA 1 year after OSA treatment. Authors believe OSA inflammatory processes interact with OSA hypoxia-induced erythropoiesis. |
|
| SA | Mean 42–66 | Case-control | OSA | AHI > 10 events/h of sleep for females and >15 events/h for males. | Sleepiness | Apnoeic males were significantly sleepier than controls. CPAP improved subjective sleepiness. | OSA is associated with sleepiness, inflammation and insulin resistance, even in non-obese males, and this association is stronger in males than in females. Short-term CPAP does not improve the inflammatory/metabolic aberrations in OSA. | |
| 8 | IL-6 | Apnoeic males had significantly higher IL-6 than controls. Apnoeic females had IL-6 similar to controls. CPAP did not change IL-6 | |||||||
| TNFR-1 | No significant difference was observed in TNFR-1 values. CPAP did not change TNFR-1 | ||||||||
| Leptin and adiponectin | Apnoeic males had significantly higher leptin than controls. Apnoeic females had leptin and adiponectin similar to controls. CPAP did not change leptin and adiponectin | ||||||||
| hsCRP | Apnoeic males and females had significantly higher hsCRP. CPAP did not change hsCRP. | ||||||||
| Fasting glucose and insulin levels | Apnoeic males had significantly higher insulin resistance than controls. Apnoeic females had insulin resistance similar to controls. CPAP did not change insulin resistance. | ||||||||
|
| SA and tetraplegia | 18–60 | Case-control | 7 | OSA | AHI > 15 per hour of sleep. | Neuropsychological function (e.g., memory, perception, attention, and concentration) | The neuropsychological functions most affected by nocturnal desaturation were verbal attention and concentration, immediate and short-term memory, cognitive flexibility, internal scanning and working memory. | SA impairs daytime cognitive function in tetraplegia patients, particularly attention, concentration, memory and learning skills. Cognitive disturbances resulting from SA might adversely affect rehabilitation in patients with tetraplegia. |
|
| SA | 20–80 | Cohort | 9 | OSA | Mild OSA = AHI 5–14.9 events/h, and moderate OSA = AHI 15–29.9 events/h. All cases were without hypertension at the baseline. | Incident hypertension | Mild-to-moderate OSA was significantly associated with increased risk of incident hypertension. | Mild-to-moderate OSA, even when asymptomatic, is associated with increased risk of incident hypertension, but the strength of association significantly decreases with age. |
|
| SA | Mean 52.5 | Cross-sectional | 7 | OSA | Mild to severe OSA (AHI and ODI ≥ 5) and severe OSA (AHI and ODI ≥ 15). | A score quantifying age-related brain patterns in 169 brain regions | AHI and ODI were both positively associated with brain age. The effects remained stable in the presence of various confounders such as diabetes and were partially mediated by the white blood cell count, indicating a subclinical inflammation process. | The study reveals an association between OSA and brain age, indicating subtle but widespread age-related changes in regional brain structures. |
|
| SA | 18–70 | Cross-sectional | 6 | OSA | AHI | Vascular function, and arterial stiffness | FMD was impaired in patients with OSA. OSA did not significantly influence vascular function in the skin microcirculation. The augmentation index, a measure of arterial stiffness, was similar between the OSA and control groups, OSA independently predicted the augmentation index in men only. | In obesity, both OSA and aging impair endothelial function and increase arterial stiffness. |
The effects of sleep apnea on aging markers (leukocyte telomere length) and age-related diseases.
| Author, year (ref.) | Conditions | Age in years | Study design | Total quality score | Type of sleep apnea | Sleep apnea criteria | Aging markers | Results | Conclusion |
|
| SA | 49.5 | Case-control | 7 | OSAS | AHI | LTL | TL was significantly shorter in patients with OSAS than in controls. This difference persisted after adjustment for age, presence of cardiovascular and metabolic changes. TL was not related to the severity of OSAS. | TL in circulating leukocytes is shorter in patients with OSAS than controls. The mechanism of this observation is unresolved since it appears independent of chronological age, the severity of OSAS and/or the presence of cardiovascular or metabolic changes. |
|
| SA | 44–84 | Cohort | 9 | OSA | AHI | LTL | Severe obstructive sleep apnea was associated with shorter LTL. An exploratory analysis found that higher arousal index at Exam 5 was associated with greater LTL decline over the prior 10 years. | OSA was associated with shorter leukocyte telomere length. Individuals with high arousal frequency had greater leukocyte telomere attrition over the prior decade. These findings suggest that sleep apnea and sleep fragmentation are associated with accelerated biological aging. |
|
| SA | 46.8 | Case-control | 6 | OSAS | AHI | LTL | AHI and oxygen desaturation index were significantly related to telomere shortening. | Intermittent hypoxemia due to OSAS is a major contributor to telomere shortening in middle-aged men. Oxidative stress may explain this finding. |
|
| SA | 5–10 | Case-control | 8 | OSA | AHI | LTL | LTL was independently associated with AHI. | In pediatric OSA, LTL is longer rather than shorter. Children with OSA have reduced plasma catestatin levels and increased BP along with increased MRP 8/14 levels that exhibit AHI dependencies. Thus, catestatin and MRP 8/14 levels may serve as biomarkers for cardiovascular risk in the context of pediatric OSA. However, the implications of increased LTL in children with OSA remain to be defined. |
| Catestatin | Children with OSA exhibited lower plasma catestatin. | ||||||||
| MRP 8/14 | Children with OSA exhibited higher MRP 8/14 levels than controls | ||||||||
|
| SA | 45.6 | Case-control | 7 | OSA | RDI ≥ 5 | LTL | Significantly shortened TL was observed in the circulating leukocytes of the peripheral blood of OSA patients, and TL shortening was aggravated more acutely in an age- and BMI-dependent manner. | The results provided evidence that telomere length shortening or excessive cellular aging might be distinctive in circulating leukocyte of OSA patients. |
|
| SA | 58.9 years | Cohort | 9 | OSA | AHI ≥ 5 | LTL | Sleep stability significantly reduced with shortened LTL in OSA patients. | The present study suggested that shorter LTL might contribute to reduced sleep stability by interacting with OSA severity due to the stress of chronic sleep fragmentation or invariant sympathetic activity by respiratory chemoreflex activation. |
|
| SA | 35.6 (cases) and 47.3 (controls) | Case-control | 8 | OSA | AHI ≥ 5 | LTL | The OSA group had a higher likelihood of cancer but no clear evidence of an elevated incidence of MACE compared to the non-OSA group. There was no association between TL and MACE or cancer-risk. | The study warrants further investigation of any modulating effect of OSA on TL and the risk of MACE and cancer. |
|
| SA | 27–57 | Case-control | 7 | OSA | AHI ≥ 5 | LTL | There was no difference in telomere length between OSA and control group. The mean TL in moderate-to-severe OSA was significantly longer than in control group after adjustment for age, sex, BMI, hypertension, dyslipidemia and depression. | Moderate-to-severe OSA is associated with telomere lengthening. These findings support the idea that changes in TL are not unidirectional processes such that telomere shortening occurs with age and disease, but may be prolonged in moderate-to-severe OSA. |
|
| SA | 30–55 | Case-control | 9 | OSA | High risk of having OSA if scores were positive for two or more of the three categories by Berlin questionnaire. | LTL | The study showed that LTL varied by OSA risk in women. Multiple linear regression analysis confirmed that women at higher risk for OSA presented shorter LTL compared to those at lower risk. These differences were not observed in men. | These findings suggest that OSA risk may contribute to the acceleration of cellular aging processes through telomere shortening. |
|
| SA | 20–80 | Case-control | 8 | OSAS | AHI > 5 | LTL | LTL was significantly shorter in OSAS patients compared to controls. | The study indicates the presence of an association between LTL and OSAS and a significant impact of severity of OSAS in telomeres shortening. |
FIGURE 2Effects of intermittent hypoxia depending on dose. HIF-1α, hypoxia inducible factor-1α; ROS, reactive oxygen species; Nox, nicotinamide adenine dinucleotide phosphate oxidase; eNOS, endothelial nitric oxide synthase; TERT, telomerase reverse transcriptase; TL, telomere length; EPO, erythropoietin; Hb, hemoglobin content; Hct, hematocrit; IHT, intermittent hypoxic training; OSA, obstructive sleep apnea.